Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial [Original Articles]

Conclusions:
Black patients with HFpEF have a higher HF hospitalization risk than nonblack patients, but spironolactone is similarly effective and safe in both groups.

Clinical Trial Registration:
URL: https://www.clinicaltrials.gov. Unique identifier: NCT00094302.

Source: Circulation: Heart Failure - March 16, 2018 Category: Cardiology Authors: Lewis, E. F., Claggett, B., Shah, A. M., Liu, J., Shah, S. J., Anand, I., OMeara, E., Sweitzer, N. K., Rouleau, J. L., Fang, J. C., Desai, A. S., Retta, T. M., Solomon, S. D., Heitner, J. F., Stamos, T. D., Boineau, R., Pitt, B., Pfeffer, M. A. Tags: ACE/Angiotensin Receptors/Renin Angiotensin System, Clinical Studies, Cardiomyopathy, Heart Failure Original Articles Source Type: research